-
Something wrong with this record ?
A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats
J. Kassa, J. Misik, JZ. Karasova,
Language English Country England, Great Britain
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
NLK
Medline Complete (EBSCOhost)
from 2004-01-01 to 1 year ago
Wiley Online Library (archiv)
from 1997-01-01 to 2012-12-31
- MeSH
- Muscarinic Antagonists therapeutic use MeSH
- Antidotes adverse effects therapeutic use MeSH
- Atropine therapeutic use MeSH
- Autonomic Nervous System drug effects physiopathology MeSH
- Chemical Warfare Agents chemistry toxicity MeSH
- Cholinesterase Inhibitors chemistry toxicity MeSH
- Drug Therapy, Combination MeSH
- Rats MeSH
- Lethal Dose 50 MeSH
- Neurons drug effects MeSH
- Neurotoxicity Syndromes drug therapy physiopathology MeSH
- Obidoxime Chloride adverse effects therapeutic use MeSH
- Oximes adverse effects therapeutic use MeSH
- Rats, Wistar MeSH
- Psychomotor Performance drug effects MeSH
- Pyridinium Compounds adverse effects therapeutic use MeSH
- Cholinesterase Reactivators adverse effects therapeutic use MeSH
- Sarin antagonists & inhibitors toxicity MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Geographicals
- Czech Republic MeSH
The neuroprotective effects of a newly developed oxime K203 and currently available oximes (obidoxime, HI-6) in combination with atropine in rats poisoned with sarin were studied. The sarin-induced neurotoxicity was monitored using a functional observatory battery at 2 hr after sarin challenge. The results indicate that the potency of a novel bispyridinium oxime K203 to counteract sarin-induced neurotoxicity is relatively low and roughly corresponds to the neuroprotective efficacy of obidoxime. Among tested oximes, the oxime HI-6 seems to be significanlty more efficacious to counteract acute neurotoxicity of sarin than commonly used obidoxime and a newly developed oxime K203. Thus, the oxime K203 does not provide any beneficial effect for the antidotal treatment of acute poisoning with sarin in comparison with the oxime HI-6 that should be considered to be the best oxime for antidotal treatment of acute sarin poisonings.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012698
- 003
- CZ-PrNML
- 005
- 20130410093230.0
- 007
- ta
- 008
- 130404s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1742-7843.2012.00897.x $2 doi
- 035 __
- $a (PubMed)22536919
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kassa, Jiri $u Department of Toxicology, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic. kassa@pmfhk.cz
- 245 12
- $a A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats / $c J. Kassa, J. Misik, JZ. Karasova,
- 520 9_
- $a The neuroprotective effects of a newly developed oxime K203 and currently available oximes (obidoxime, HI-6) in combination with atropine in rats poisoned with sarin were studied. The sarin-induced neurotoxicity was monitored using a functional observatory battery at 2 hr after sarin challenge. The results indicate that the potency of a novel bispyridinium oxime K203 to counteract sarin-induced neurotoxicity is relatively low and roughly corresponds to the neuroprotective efficacy of obidoxime. Among tested oximes, the oxime HI-6 seems to be significanlty more efficacious to counteract acute neurotoxicity of sarin than commonly used obidoxime and a newly developed oxime K203. Thus, the oxime K203 does not provide any beneficial effect for the antidotal treatment of acute poisoning with sarin in comparison with the oxime HI-6 that should be considered to be the best oxime for antidotal treatment of acute sarin poisonings.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidota $x škodlivé účinky $x terapeutické užití $7 D000931
- 650 _2
- $a atropin $x terapeutické užití $7 D001285
- 650 _2
- $a autonomní nervový systém $x účinky léků $x patofyziologie $7 D001341
- 650 _2
- $a chemické bojové látky $x chemie $x toxicita $7 D002619
- 650 _2
- $a cholinesterasové inhibitory $x chemie $x toxicita $7 D002800
- 650 _2
- $a reaktivátory cholinesterasy $x škodlivé účinky $x terapeutické užití $7 D002801
- 650 _2
- $a kombinovaná farmakoterapie $7 D004359
- 650 _2
- $a LD50 $7 D007928
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a antagonisté muskarinových receptorů $x terapeutické užití $7 D018727
- 650 _2
- $a neurony $x účinky léků $7 D009474
- 650 _2
- $a neurotoxické syndromy $x farmakoterapie $x patofyziologie $7 D020258
- 650 _2
- $a obidoxim chlorid $x škodlivé účinky $x terapeutické užití $7 D009768
- 650 _2
- $a oximy $x škodlivé účinky $x terapeutické užití $7 D010091
- 650 _2
- $a psychomotorický výkon $x účinky léků $7 D011597
- 650 _2
- $a pyridinové sloučeniny $x škodlivé účinky $x terapeutické užití $7 D011726
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a sarin $x antagonisté a inhibitory $x toxicita $7 D012524
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Misik, Jan $u -
- 700 1_
- $a Karasova, Jana Zdarova $u -
- 773 0_
- $w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 111, č. 5 (2012), s. 333-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22536919 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130410093459 $b ABA008
- 999 __
- $a ok $b bmc $g 975896 $s 810979
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 111 $c 5 $d 333-8 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
- LZP __
- $a Pubmed-20130404